Drawing for EVOLVA

USPTO serial 79011965

EVOLVA

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
KHAN, ASMAT A
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EVOLVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Polynucleic acids and polypeptides for scientific, research and commercial use; chemicals for scientific use, research and commercial use, the aforementioned to be used in vitro and in vivo; plant growth regulators, polypeptides, genes, and other genetic material for agricultural use; genes and enzymes used to produce chemicals for research and commercial applications pertaining to chemistry, biochemistry, biology, agriculture, pharmaceuticals, diagnostics, medicine, cosmetics, bioremediation, decontamination, detoxification and cleaning, transgenic micro organisms, libraries of micro organisms, nanostructuresSECTION 70 - CANCELLED—
005Pharmaceutical, medical and veterinary preparations, drugs, nutraceuticals, gene therapy products, medical and pharmaceutical screening products, enzymes and enzyme preparations for medical and veterinary purposes, medical diagnostic preparations and reagents composed of polynucleic acids and polypeptides; herbicides, pesticides, biopesticides, miticides and weed-killers, all for agricultural and domestic use; vaccines, adjuvants for use with vaccines; intermediate semi-synthetic drugs, hormonesSECTION 70 - CANCELLED—
042Scientific and industrial research, in particular drug discovery, cell discovery, gene research, enzyme research, molecular research, genomics and gene expression research and development, medical and pharmaceutical screening, development and creation of gene libraries, generation of molecules; development of combination of genes to produce novel gene pathways for use in science, research, chemistry, agriculture, medicine and industry; research and product development services in the field of genetics, pharmaceuticals, bacteriology, virology, metabolic pathways and biochemical pathwaysSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2015DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jan 22, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 5, 2006FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 15, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 14, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 16, 2006ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 13, 2006MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 12, 2006ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 26, 2005RFNTREFUSAL PROCESSED BY IB—
Aug 15, 2005IRRFIRREGULARITY ON REFUSAL FROM IB—
Aug 9, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 5, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 4, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2005DOCKASSIGNED TO EXAMINER—
Jul 29, 2005NWAPNEW APPLICATION ENTERED—
Jul 28, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance